Site Map Search Contact Us |
||
| About Us | Programs & Pipeline | News | Investors | Bus. Development |
![]() |
Hepatitis C Virus (HCV) | Intellectual Property | ![]() |
Intellectual PropertyPresidio has an extensive IP portfolio for its HCV programs. This portfolio provides the Company with a strong patent position on all development compounds. Presidio Pharmaceuticals, Inc. |